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Abstract
The association between isolate genotype, deﬁned as in the international spoligotype database SpolDB4, and extrapulmonary tuberculosis
was determined among 1009 patients in a population-based, 4-year survey performed in Tuscany, Italy. Extrapulmonary disease
occurred in 24.2% of patients. A statistically signiﬁcant association with extrapulmonary disease was found for the BOVIS (adjusted
OR 3.2; 95% CI 1.2–8.1) and for the Central Asian (CAS) lineages (adjusted OR 2.3; 95% CI 1.0–5.1). These ﬁndings support the view
that Mycobacterium tuberculosis strains within individual genotypic lineages might have evolved unique pathogenic characteristics that are
capable of inﬂuencing the clinical outcome of the infection.
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Introduction
In the past, much tuberculosis (TB) research was based on the
assumption that TB is caused by a highly conserved strain
of Mycobacterium tuberculosis. However, recent studies on the
genomics and molecular evolution of M. tuberculosis have
shown that the organism has evolved in large, geographically
constrained, clonal lineages, without horizontal genetic
exchanges, thus yielding a large clonal population of genotypi-
cally and phenotypically different lineages, potentially endowed
with different properties that can impact on the virulence of
the organism and the consequent disease [1,2]. Although it has
long been known, mainly through animal studies, that certain
strains show increased virulence [2], there is little compelling
evidence that speciﬁc genetic lineages show peculiar pathoge-
netic properties in humans. The possible exception concerns
the strains of the Beijing genetic lineage, which, in certain
settings, have been shown to be capable of spreading rapidly
in large clonal clusters [3], and have been linked with extrapul-
monary TB or with treatment failure and relapse [4–7]; in ani-
mal studies, Beijing strains induced a more severe pathology
than other M. tuberculosis genotypes, and elicited a distinct
immune response with a reduced cytokine response, resulting
in a failure to induce Th1-type immunity [2,8,9].
The ability of a strain to disseminate and cause extrapul-
monary TB is considered a marker of virulence. In fact, the
increased infectivity of strains that are found at extrapulmo-
nary locations has been demonstrated by the studies of Gar-
cia de Viedma et al. [10]. In the present study, the association
of extrapulmonary TB with the M. tuberculosis genotypic
lineages deﬁned in the SpolDB4 database [11] using the
spacer oligonucleotide typing assay (spoligotyping) [12] was
determined in a population-based, 4-year survey performed
in Tuscany, Italy, a region with a low prevalence of TB, where
different autochthonous and imported M. tuberculosis geno-
typic lineages coexist, owing to a recent increase in immigra-
tion from high-prevalence countries [13].
Materials and Methods
Clinical isolates and patients
A total of 1009 M. tuberculosis complex strains, collected by
the Regional Reference Centre for Mycobacteria, Florence,
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Italy, during a 4-year study period from 1 January 2002 to 31
December 2005 from the same number of TB patients (563
Italian-born; 446 foreign-born), admitted to ten major com-
munity hospitals in Tuscany, Italy, were studied. The study
isolates represent the majority (>90%) of the total isolates in
the region during the study period. All isolates were identi-
ﬁed by DNA probes (Accuprobe (Gen-Probe, San Diego,
CA, USA) and/or InnoLipa (Innogenetics, Gent, Belgium)).
Mycobacterium bovis BCG isolates were not included in the
present study. The patients’ clinical records were reviewed
in order to classify the disease as pulmonary or extrapulmo-
nary. Twelve patients with concomitant pulmonary and ex-
trapulmonary disease were placed in the extrapulmonary
disease group (Table 1).
Spoligotyping
Spoligotyping analysis of isolates was performed as described
by Kamerbeek et al. [12]. Brieﬂy, genomic mycobacterial
DNA was extracted from the bacteria grown on ADC-sup-
plemented Middlebrook 7H9 or Lowenstein–Jensen medium
(Becton Dickinson, Baltimore, MD, USA) by the cetyltrime-
thylammonium bromide method. The oligonucleotides DRa
and DRb were used as primers to amplify the whole direct
repeat (DR) region by PCR. The ampliﬁed biotinylated prod-
ucts were hybridized to a set of 43 immobilized oligonucleo-
tides, each corresponding to one of the unique spacer DNA
sequences within the DR locus. After hybridization, the
membrane was washed, incubated in streptavidin–peroxidase
conjugate (Boehringer, Mannheim, Germany), and ﬁnally
developed by chemoluminescence. M. tuberculosis complex
isolates were assigned to one of the genotypes (or families)
deﬁned in the international spoligotype database SpolDB4 of
the Pasteur Institute of Guadeloupe, France [11]. The cur-
rently accepted nomenclature of the genotypic lineages of
SpolDB4 was also retained, to refer to clades BOVIS and AF-
RICANUM, given in capital letters, which essentially include
the species M. bovis and Mycobacterium africanum of the
M. tuberculosis complex.
Statistical analysis
The associations of extrapulmonary TB with the M. tuberculosis
genotypes were assessed by univariate chi-square test and
multiple logistic regression. In the multiple logistic regression,
each genotype was included in the model as a dummy variable
by using the T genotype as a reference category. This
approach allowed assessment of the relative importance of
each genotype in predicting the probability of extrapulmonary
localization. The T genotype was used as a referent because it
was the largest genotype and showed a proportion of pulmo-
nary and extrapulmonary TB comparable to that of the overall
study population (Table 1). Analysis was performed by SAS
software, version 8.2 (SAS Institute, Cary, NC, USA).
Results and Discussion
A total of 1009 strains of M. tuberculosis complex, isolated
during a 4-year period in Tuscany, Italy, were genotyped by
TABLE 1. Distribution of pulmonary and extrapulmonary tuberculosis cases classiﬁed according to major Mycobacterium
tuberculosis genotypic lineages during the period 2002–2005 in Tuscany, Italy
Genotype
No. of isolates (%)
Association of genotypes with extrapulmonary diseasea
Univariate v2 Multiple logistic regression
Pulmonary Extrapulmonaryb Total v2 p Adjusted OR 95% CI p
Africanum 8 (57.1) 6 (42.9) 14 2.65 NS 2.139 0.718–6.368 NS
Beijing 60 (82.2) 13 (17.8) 73 1.82 NS 0.618 0.321–1.190 NS
Bovis 8 (47.1) 9 (52.9) 17 8.43 0.004 3.168 1.239–8.100 0.016
CAS 15 (55.6) 12 (44.4) 27 6.10 0.014 2.281 1.021–5.097 0.044
EAI 35 (77.8) 10 (22.2) 45 0.114 NS 0.815 0.384–1.726 NS
Haarlem 178 (82.4) 38 (17.6) 216 6.780 0.009 0.609 0.392–0.944 0.027
LAM 98 (76.0) 31 (24.0) 129 0.007 NS 0.902 0.556–1.462 NS
S 44 (84.6) 8 (15.4) 52 2.383 NS 0.518 0.233–1.152 NS
T 211 (74.0) 74 (26.0) 285 0.577 NS 1.000 – –
X 10 (83.3) 2 (16.7) 12 0.387 NS 0.570 0.122–2.663 NS
Othersc 4 (100.0) 0 (0.0) 4 – – – – –
Undeﬁnedd 94 (69.6) 41 (30.4) 135 3.090 NS 1.244 0.791–1.955 NS
Total 765 (75.8) 244 (24.2) 1009 – – – – –
NS, not signiﬁcant.
aAssessed by univariate chi-square test and multiple logistic regression model using the T genotype as a referent.
bThis group includes a total of 12 isolates with concomitant pulmonary and extrapulmonary localization (four of T genotype; three of Haarlem genotype; two of CAS
genotype; two of Beijing genotype; one of undeﬁned genotype).
cThis group contains two isolates with a signature attributable to the Haarlem or S family, one isolate with a signature attributable to the Haarlem or T family, and one
isolate of MANU family.
dStrains with a signature that is as yet undeﬁned in SpolDB4.
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spoligotyping and assigned to one of the clades deﬁned
in the international spoligotype database SpolDB4 of the
Pasteur Institute of Guadeloupe, France [11]. Spoligotyping
identiﬁed ten major genotypic families, namely, AFRICANUM
(1.4% of total isolates), Beijing (7.2%), BOVIS (1.7%), Central
Asia (CAS) (2.7%), East Africa–India (EAI) (4.5%), Haarlem
(21.4%), Latin American–Mediterranean (LAM) (12.8%),
S (5.2%), T (28.2%), X (1.2%), and other spoligotypes unde-
ﬁned in SpolDB4 (13.8%). The distribution of pulmonary and
extrapulmonary TB among the genotype families is reported
in Table 1. As shown, the extrapulmonary disease accounted
for 244 cases (24.2%); extrapulmonary TB cases ranged from
15% for isolates of the S genotype to 53% for isolates of the
BOVIS genotype. Using the T genotype as a referent, both
univariate chi-square test and multiple logistic regression
indicated that extrapulmonary TB is signiﬁcantly associated
with infection by isolates of the BOVIS genotype (adjusted
OR 3.2; 95% CI 1.2–8.1) and isolates of the CAS genotype
(adjusted OR 2.3; 95% CI 1.0–5.0). For the AFRICANUM
genotype, the percentage of extrapulmonary TB cases was as
high as 43%, but it did not reach statistical signiﬁcance, owing
to the small numbers.
The epidemiological features of patients with TB caused
by the BOVIS and CAS genotypes are reported in Table 2.
Most patients with TB caused by the BOVIS genotype (11/
17) were Italian-born, and ranged from 33 to 93 years of age
(mean, 69 years), which probably indicates, at least in most
cases, a reactivation of an M. bovis infection acquired long
before; according to clinical records, there was a previous
TB episode for only one Italian-born, 74-year-old patient.
The six foreign-born patients with BOVIS TB were young
(mean age, 28 years; range, 21–38 years), thus indicating
a recently acquired infection. All BOVIS isolates were
susceptible to rifampin; nine/14 tested isolates (64%) were
resistant to pirazinamide; two isolates were resistant to
isoniazid; and two isolates were resistant to ethambutol.
No association between drug resistance and extrapulmonary
TB was observed. On the other hand, all patients with TB
caused by the CAS strains were young (mean age, 32 years;
range, 20–45 years) and foreign-born, being mostly from
South Asia, especially Pakistan and India, and from Africa;
according to clinical records, among the 27 patients there
was no previous TB episode for 19 patients, and this infor-
mation was unknown for eight patients. This suggests that
the CAS patients acquired infection in their countries of
origin and developed the disease after arrival in the host
country. In general, all CAS isolates were susceptible to
ﬁrst-line anti-TB drugs, with the exception of two isolates
resistant to isoniazid, and two isolates resistant to pirazina-
mide; no multidrug resistance was observed among the
isolates. Human immunodeﬁciency virus status, when
known, was negative for all patients harbouring BOVIS or
CAS genotypes, thus ruling out human immunodeﬁciency
virus infection as a factor inﬂuencing the extrapulmonary
localization of TB for both genotypes.
The molecular characteristics of the BOVIS and CAS iso-
lates are shown in Table 3. A total of seven different spoligo-
type shared types (an identical pattern shared by two or
more patients, referred to as Spoligotype International Types
(SITs)) were detected for the BOVIS genotype; SIT 482
(BOVIS1_BCG clade) was prevalent. Typing of BOVIS iso-
lates by the potentially highly discriminatory variable-number
tandem repeat–mycobacterial interspersed repetitive units
(VNTR-MIRU) assay [14] was not performed, because, unlike
for M. tuberculosis isolates, whose VNTR-MIRU proﬁle is
generally considered to be an individual marker equivalent to
TABLE 2. Epidemiological features of patients with pulmonary and extrapulmonary tuberculosis caused by Mycobacterium
tuberculosis of the BOVIS or CAS genotypic lineages
Patients
Lineage
BOVIS CAS
Pulmonary Extrapulmonary Pulmonary Extrapulmonary
Male/female ratio 2.5 0.3 3.7 3.0
Agea 60 (21–80) 51 (24–93) 33 (24–45) 31 (20–44)
Country of birthb Italy (6) Italy (5) Pakistan (11) Pakistan (6)
Morocco (1) Morocco (2) India (1) India (2)
Peru (1) Philippines (2) Iraq (1) Somalia (2)
Ivory Coast (1) Cameroun (1)
Unknown (1) Unknown (1)
HIV statusb Negative (3) Negative (8) Negative (14) Negative (9)
Unknown (5) Unknown (1) Unknown (1) Unknown (3)
HIV, human immunodeﬁciency virus.
aExpressed as mean (the range is given in parentheses).
bThe number of tuberculosis patients is given in parentheses.
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the reference IS6110 restriction fragment length polymor-
phism proﬁle, the assay is poorly discriminatory for M. bovis
isolates [15]. For the isolates of the CAS genotype, ﬁve dif-
ferent SITs were detected; SITs 25 and 26 (CAS1_DELHI
clade) were prevalent. According to VNTR-MIRU typing, the
27 CAS isolates yielded 18 unique patterns and four distinct
clusters including a total of nine isolates (data not shown);
interestingly, all clustered isolates were SIT 26. No particular
SIT or VNTR-MIRU proﬁle was predominant in the cases of
extrapulmonary TB. The high molecular diversity of the CAS
isolates rules out the possibility that the CAS population of
the study contained only a few predominant genotypes.
Finally, the analysis showed a signiﬁcant association
between the Haarlem genotype and pulmonary disease
(OR 1.6; 95% CI 1.1–2.5). This suggests that the Haarlem
lineage is less invasive, as the bacteria have a propensity to
remain localized in the lung, an observation that needs to be
reconﬁrmed in other settings where the Haarlem genotype
predominates.
The association of the BOVIS genotypic lineage with ex-
trapulmonary TB was not unexpected. Although the relative
virulence of M. bovis, as compared with M. tuberculosis, for
humans remains unknown, several reports from western
countries have underscored the prevalence of extrapulmo-
nary localization of M. bovis; for example, in a study per-
formed in England in the late 1970s, bovine strains caused a
high incidence of extrapulmonary disease among the Euro-
pean and Afro-Asian patients [16]; and in studies performed
in California, USA, extrapulmonary M. bovis TB was found in
as many as, or over, 50% of the patients [17,18]. Studies
in animals support the possibility of an enhanced ability of
M. bovis, over M. tuberculosis, to cause extrapulmonary
disease [19]. However, it must be considered that the high
proportion of extrapulmonary localization of BOVIS TB,
reported in the present article and in the other studies men-
tioned above [16–18], may not necessarily reﬂect the pro-
pensity of strains of the BOVIS lineage to disseminate, but
rather the different route of exposure to these organisms,
which usually involves contaminated food (especially milk) or
direct contact with infected animals.
There are no reports, to our knowledge, that have associ-
ated the CAS genotypic lineage with extrapulmonary TB,
although a number of reports from western countries have
linked extrapulmonary localization to the geographical origin
and/or the immigrant status of patients. In fact, previous
studies conducted in the USA and Europe found greater pro-
portions of patients with extrapulmonary disease among for-
eign-born than among native-born cases of TB, especially
among patients born in the Middle East, India, other Asian
countries (excluding China, Japan, and countries of the for-
mer Soviet Union), and sub-Saharan Africa [20–30]. The
above-mentioned geographical areas simply mirror the geo-
graphical distribution of the CAS genotype in the SpolDB4
database; in fact, the CAS lineage, particularly the CAS1-
DELHI clade, is essentially localized in South Asia, prefer-
entially in India, in other countries of the Middle-East, e.g.
Pakistan and Iran, and in several other regions, including
Africa [11]. Thus, the long-established link of extrapulmonary
TB with the South Asian or African origin of patients might
be interpreted on the grounds of as yet undeﬁned speciﬁc
bacterial properties of the CAS genotypic lineage infecting
these patients. It should be mentioned, however, that in a
study from Pakistan, where CAS1 strains were highly preva-
lent, accounting for 39% of isolates, no statistically signiﬁcant
association of CAS1 strains with extrapulmonary TB was
found [31]. As all cases of CAS TB in the present survey
TABLE 3. Molecular characteristics of pulmonary and extrapulmonary Mycobacterium tuberculosis isolates of the BOVIS and
CAS genotypic lineages
Lineage
Spoligotype description No. of isolates
SITa Binary formatb Octal format Pulmonary Extra-pulmonary
BOVIS 482 jjhjjjjjhjjjjjjhjjjjjjjjjjjjjjjjjjjjjjhhhhh 676773777777600 5 6
672 jjhjjhjhhhhhjjhhjjjjjjjjjjjjjjjjjjjjjjhhhhh 664063777777600 1 –
1842 jhhjjjjjhjjjjjhhjjjjjjjjjjjjjjjjjjjjjjhhhhh 476763777777600 – 1
Orphanc jjhjjjjjhhjjhhhhjjjjjjjjjjjjjjjjjjjjjjhhhhh 676303777777600 1 –
Orphan jjhjjhjjhjjjjjhhjjjjjjjjjjjjjjjjjjjjjjhhhhh 666763777777600 1 –
Orphan jjjjjjhhhhjjjjhhjjjjjjjjjjjjjjjjjjjjjjhhhhh 770363777777600 – 1
Orphan jjhjjjjhhjjjjjhhjjjjjjjjjjjjjjjjjjjjjjhhhhh 674763777777600 – 1
CAS 25 jjjhhhhjjjjjjjjjjjjjjjhhhhhhhhhhhhjjhhjjjjj 703777740003171 1 4
26 jjjhhhhjjjjjjjjjjjjjjjhhhhhhhhhhhhjjjjjjjjj 703777740003771 12 7
1092 jjjhhhhjhjjjjjjjjjjjjjhhhhhhhhhhhhjjjjjjjjj 703777740003771 1 –
1551 jjjhhhhhjjjjjjjjjjjjjjhhhhhhhhhhhhjjjjjjjjj 701777740003771 – 1
Orphan jjjhhhhhhhjjjjjjjjjjjjhhhhhhhhhhhhhhhhhhhjj 700377740000011 1 –
aSpoligotype International Type (SIT) designations were assigned according to the deﬁnition in the SpolDB4 database.
bThe black and white boxes indicate the presence and absence, respectively, of the speciﬁc spacer at positions 1–43 in the direct repeat (DR) locus.
cOrphan isolate (identical pattern unavailable in the SpolDB4 database).
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involved foreign-born individuals, the possible delay in diag-
nosis and treatment of TB infection in these patients may
have caused the progression of primary TB infection to ex-
trapulmonary sites.
In the present survey, a low percentage (18%) of extrapul-
monary localization was observed among cases of Beijing TB;
similarly, a study performed in South Africa also failed to
demonstrate an association between Beijing strains and the
propensity to cause extrapulmonary disease [32]. These data
contrast with those of Kong et al. [5], who reported that
patients infected with the Beijing strains were nearly three
times as likely as patients infected with the non-Beijing
strains to have extrathoracic involvement, suggesting that the
Beijing strains may have some special biological features that
facilitate the development of extrathoracic TB. However,
other studies have indicated that only certain sublineages of
the Beijing family show peculiar pathogenic features; for
example, extrathoracic Beijing TB was found to be associated
only with sublineages bearing speciﬁc genomic deletions in
one study [4], and in another study, only a recently evolved
Beijing sublineage showed an increased ability to be transmit-
ted (and to cause disease). Nonetheless, an association
between the sublineage and clinical parameters could not be
demonstrated [33].
In conclusion, the present data lend support to the view
that the pathogenic properties of M. tuberculosis are not evenly
conserved among the genotypic lineages of the M. tuberculosis
complex, and that strains within individual lineages or sublin-
eages might have evolved unique pathogenic characteristics
that inﬂuence the clinical outcome of the infection.
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